Detalhe da pesquisa
1.
Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
Dis Model Mech
; 9(7): 749-57, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27149990